Pharmacologic advances in seizure control.
D000927:Anticonvulsants / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D002220:Carbamazepine / Q000009:adverse effects / Q000378:metabolism; D002648:Child; D002998:Clonazepam / Q000009:adverse effects / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D010672:Phenytoin / Q000009:adverse effects / Q000378:metabolism; D012640:Seizures / Q000517:prevention & control*; D013226:Status Epilepticus / Q000188:drug therapy; D014635:Valproic Acid / Q000009:adverse effects / Q000378:metabolism
D000927:Anticonvulsants; D002220:Carbamazepine; D002998:Clonazepam; D014635:Valproic Acid; D010672:Phenytoin